Contribution of allelic variability in prostate specific antigen (PSA) & androgen receptor (AR) genes to serum PSA levels in men with prostate cancer

被引:0
作者
Chavan, Sushant V. [1 ]
Maitra, Anurupa [2 ]
Roy, Nobhojit [3 ]
Chavan, Padma R. [4 ]
机构
[1] Lokmanya Tilak Municipal Gen Hosp & Med Coll, Dept Biochem, Bombay, Maharashtra, India
[2] Natl Inst Res Reprod Hlth, Dept Mol Endocrinol, Bombay, Maharashtra, India
[3] Bhabha Atom Res Ctr Hosp, Dept Surg, Bombay, Maharashtra, India
[4] MGM Med Coll, Dept Biochem, Kamothe 410209, Navi Mumbai, India
关键词
Androgen receptor; polymorphism; prostate cancer; prostate specific antigen; SNP; REGULATED ACTIVITY; G/A POLYMORPHISM; RESPONSE ELEMENT; ENHANCER REGION; RISK; ASSOCIATION; VARIANTS; SURVIVAL; RS266882; PROMOTER;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background & objectives: Wide variability in serum prostate specific antigen (PSA) levels exists in malignant conditions of the prostate. PSA is expressed in normal range in 20 to 25 per cent of prostate cancer cases even in presence of high grade Gleason score. This study was aimed to assess the influence of genetic variants exhibited by PSA and androgen receptor (AR) genes towards the variable expression of PSA in prostate cancer. Methods: Pre-treatment serum PSA levels from 101 prostate cancer cases were retrieved from medical record. PSA genotype analysis in promoter region and AR gene microsatellite Cytosine/Adenine/Guanine (CAG) repeat analysis in exon 1 region was performed using DNA sequencing and fragment analysis techniques. Results: A total of seven single nucleotide polymorphisms (SNPs) in the PSA promoter region were noted. Only two SNPs viz., 158G/A (P<0.001) in the proximal promoter region and -3845G/A (P<0.001) in enhancer region showed significant association with serum PSA levels. The carriers of homozygous GG genotype (P<0.001) at both of these polymorphic sites showed higher expression of PSA whereas homozygous AA genotype (P<0.001) carriers demonstrated lower PSA levels. The combination effect of PSA genotypes along with stratified AR CAG repeats lengths (long, intermediate and short) was also studied. The homozygous GG genotype along with AR long CAG repeats and homozygous AA genotype along with AR short CAG repeats at position -3845 and -158 showed strong interaction and thus influenced serum PSA levels. Interpretation & conclusions: The genetic variants exhibited by PSA gene at positions -3845G/A and -158G/A may be accountable towards wide variability of serum PSA levels in prostate cancer. Also the preferential binding of G and A alleles at these polymorphic sites along with AR long and short CAG repeats may contribute towards PSA expression.
引用
收藏
页码:371 / 378
页数:8
相关论文
共 26 条
[1]   Polymorphisms in the prostate-specific antigen gene promoter do not predict serum prostate-specific antigen levels in African-American men [J].
Beebe-Dimmer, JL ;
Lange, LA ;
Cain, JE ;
Lewis, RC ;
Ray, AM ;
Sarma, AV ;
Lange, EM ;
Cooney, KA .
PROSTATE CANCER AND PROSTATIC DISEASES, 2006, 9 (01) :50-55
[2]   THE LENGTH AND LOCATION OF CAG TRINUCLEOTIDE REPEATS IN THE ANDROGEN RECEPTOR N-TERMINAL DOMAIN AFFECT TRANSACTIVATION FUNCTION [J].
CHAMBERLAIN, NL ;
DRIVER, ED ;
MIESFELD, RL .
NUCLEIC ACIDS RESEARCH, 1994, 22 (15) :3181-3186
[3]   Detection rate of prostate cancer using prostate specific antigen in patients presenting with lower urinary tract symptoms: A retrospective study [J].
Chavan, P. R. ;
Chavan, S., V ;
Chavan, N. R. ;
Trivedi, V. D. .
JOURNAL OF POSTGRADUATE MEDICINE, 2009, 55 (01) :17-21
[4]   Genetic variants in the distal enhancer region of the PSA gene and their implication in the occurrence of advanced prostate cancer [J].
Chavan, Sushant V. ;
Maitra, Anurupa ;
Roy, Nobhojit ;
Patwardhan, Sujata ;
Chavan, Padma R. .
MOLECULAR MEDICINE REPORTS, 2010, 3 (05) :837-843
[5]   An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter [J].
Cleutjens, KBJM ;
vanderKorput, HAGM ;
vanEekelen, CCEM ;
vanRooij, HCJ ;
Faber, PW ;
Trapman, J .
MOLECULAR ENDOCRINOLOGY, 1997, 11 (02) :148-161
[6]   Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter [J].
Cleutjens, KBJM ;
vanEekelen, CCEM ;
vanderKorput, HAGM ;
Brinkmann, AO ;
Trapman, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (11) :6379-6388
[7]   Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels [J].
Cramer, SD ;
Chang, BL ;
Rao, A ;
Hawkins, GA ;
Zheng, SL ;
Wade, WN ;
Cooke, RT ;
Thomas, LN ;
Bleecker, ER ;
Catalona, WJ ;
Sterling, DA ;
Meyers, DA ;
Ohar, J ;
Xu, JF .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (14) :1044-1053
[8]   PSA-based screening for prostate cancer: How does it compare with other cancer screening tests? [J].
Crawford, E. David ;
Abrahamsson, Per-Anders .
EUROPEAN UROLOGY, 2008, 54 (02) :262-273
[9]   PSA and androgen-related gene (AR, CYP17, and CYP19) polymorphisms and the risk of adenocarcinoma at prostate biopsy [J].
dos Santos, Rodrigo Mattos ;
Nobrega de Jesus, Carlos Marcio ;
Souza Trindade Filho, Jose Carlos ;
Souza Trindade, Jose Carlos ;
Viana de Camargo, Joao Lauro ;
Rainho, Claudia Aparecida ;
Rogatto, Silvia Regina .
DNA AND CELL BIOLOGY, 2008, 27 (09) :497-503
[10]   The CAG repeat within the androgen receptor gene and its relationship to prostate cancer [J].
Giovannucci, E ;
Stampfer, MJ ;
Krithivas, K ;
Brown, M ;
Brufsky, A ;
Talcott, J ;
Hennekens, CH ;
Kantoff, PW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (07) :3320-3323